WHO Recommends Twice-Yearly Lenacapavir Injection to Prevent HIV
The World Health Organization has officially recommended the use of lenacapavir, a twice-yearly injectable developed by Gilead Sciences, as a preventive measure against HIV infection.…
Black Examiner Theme Active
Winnie Byanyima Urges Affordable Pricing for Breakthrough HIV Prevention Drug Lenacapavir
UNAIDS Executive Director and UN Undersecretary-General Winnie Byanyima has called for a major and transparent reduction in the price of lenacapavir, a newly approved long-acting…
New HIV Prevention Injection Approved, But Shs102m Annual Cost Sparks Global Outcry
A newly approved HIV prevention drug, lenacapavir, has sparked global debate over its pricing, despite being hailed as a groundbreaking step in the fight against…